TG Therapeutics, Inc. (TGTX)
36.62
-0.30
(-0.81%)
USD |
NASDAQ |
Apr 24, 16:00
36.59
-0.03
(-0.08%)
After-Hours: 20:00
TG Therapeutics EPS Diluted (Quarterly) : 0.1446 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Precision BioSciences, Inc. | 1.004 |
| Krystal Biotech, Inc. | 1.699 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Geron Corp. | -0.0467 |
| Viking Therapeutics, Inc. | -1.383 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 23.04M |
| Revenue (Quarterly) | 192.57M |
| Total Expenses (Quarterly) | 169.54M |
| Enterprise Value | 5.960B |
| Gross Profit Margin (Quarterly) | 80.19% |
| Profit Margin (Quarterly) | 11.96% |
| Earnings Yield | 7.58% |
| Operating Earnings Yield | 2.09% |
| Normalized Earnings Yield | 7.587 |